Skip to search.
 TSX Up 0.08% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On NPC.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Allon Therapeutics Inc. (NPC.TO)

-Toronto

0.01 0.00(0.00%) May 22, 3:30PM EDT

Add to Portfolio
Prev Close:0.01
Open:0.01
Bid:0.01
Ask:0.01
1y Target Est:0.02
Beta:-0.05
Next Earnings Date:N/A
Day's Range:0.01 - 0.01
52wk Range:0.01 - 0.53
Volume:115,000
Avg Vol (3m):265,161
Market Cap:535.66k
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:2.66 (17.40%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Comparison

Symbol% ChgMkt Cap
NPC.TO 0.00%535.66k
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 0.94%11.88B
SUNPHARMA.NSUp 1.08%1.05T
GILD.MXDown 0.83%1.06T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:02-May-12

Analysts

Annual EPS Est (Dec-13) :-0.01
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback